Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

R. Brahmer, Julie; Lacchetti, Christina; J. Schneider, Bryan; B. Atkins, Michael; Brassil, Kelly; M. Caterino, Jeffrey; Chau, Ian; S. Ernstoff, Marc; M. Gardner, Jennifer; Ginex, Pamela; Hallmeyer, Sigrun; Holter Chakrabarty, Jennifer; B. Leighl, Natasha; S. Mammen, Jennifer; F. McDermott, David; Naing, Aung; J. Nastoupil, Loretta; Phillips, Tanyanika; Porter, Laura; Puzanov, Igor; Reichner, Cristina; Santomasso, Bianca; Seigel, Carole; I. Spira, Alexander; E. Suarez‐Almazor, María; Wang, Yinghong; S. Weber, Jeffrey; D. Wolchok, Jedd; A. Thompson, John

doi:10.1200/jco.2017.77.6385

Public

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Published in Journal of Clinical Oncology • Feb 14, 2018

Authors:

Julie R. Brahmer

Christina Lacchetti

Bryan J. Schneider

Abstract

Purpose To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy. Methods A multidisciplinary, multi-organizational panel of experts in medical oncology, dermatolog...

Subject

Medicine

Adverse effect

Guideline

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!